NCT06063629

Brief Summary

Surgical site infections (SSI) pose a common challenge in the field of surgery. Current evidence and literature do not provide clear consensus whether the use of subcutaneous drainage will help reduce the incidence of SSI in patients who underwent abdominal surgery, especially in wounds that are categorized as contaminated (class 3) or dirty/infected (class 4). The objective of this clinical study is to compare the rate of surgical site infection in contaminated and dirty/infected surgical wounds among patients whose wounds are inserted with subcutaneous drainage and patients who are not inserted with subcutaneous drainage.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 2, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

September 22, 2023

Last Update Submit

April 2, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Rate of Surgical Site Infection (SSI)

    The rate of SSI will be compared between the drain and no drain group

    Post operation day 3

  • Rate of Surgical Site Infection (SSI)

    The rate of SSI will be compared between the drain and no drain group

    Post operation day 5

  • Rate of Surgical Site Infection (SSI)

    The rate of SSI will be compared between the drain and no drain group

    Post operation day 7

  • Rate of Surgical Site Infection (SSI)

    The rate of SSI will be compared between the drain and no drain group

    Post operation day 14

  • Rate of Surgical Site Infection (SSI)

    The rate of SSI will be compared between the drain and no drain group

    Post operation day 30

Secondary Outcomes (5)

  • Length of hospital stay

    Post operation day 3

  • Length of hospital stay

    Post operation day 5

  • Length of hospital stay

    Post operation day 7

  • Length of hospital stay

    Post operation day 14

  • Length of hospital stay

    Post operation day 30

Study Arms (2)

Subcutaneous drain

EXPERIMENTAL

The drain will be inserted into subcutaneous layer of the surgical wound. Redivac drain will be used in this study.

Procedure: Subcutaneous drain

No drain

OTHER

No drain will be inserted into the surgical wound in this arm.

Procedure: No drain

Interventions

The drain will be inserted into subcutaneous layer of the surgical wound. Redivac drain will be used in this study.

Subcutaneous drain
No drainPROCEDURE

No drain will be inserted into patients allocated to this group

No drain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age equal or over 18 years old
  • Admitted to Queen Savang Vadhana Memorial Hospital
  • Receive abdominal surgery and were classified as class 3 or 4 wound

You may not qualify if:

  • Patients who undergo operation for ostomy
  • Patients who do not receive appropriate antibiotics
  • Patients who undergo operation before full recover of prior operation
  • Patients who undergo laparoscopic operation
  • Pregnant women
  • Patients who had history of prior radiation therapy at abdomen
  • Patient with immunocompromised status
  • Patient with chronic skin disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Minimization randomization
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2023

First Posted

October 2, 2023

Study Start

June 1, 2024

Primary Completion

September 1, 2024

Study Completion

February 1, 2025

Last Updated

April 4, 2024

Record last verified: 2024-04